Imunon Stock (NASDAQ:IMNN)


RevenueFinancialsChartTranscripts

Previous Close

$0.69

52W Range

$0.48 - $3.65

50D Avg

$0.97

200D Avg

$1.13

Market Cap

$9.92M

Avg Vol (3M)

$232.68K

Beta

2.13

Div Yield

-

IMNN Company Profile


Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

33

IPO Date

Mar 01, 1999

Website

IMNN Performance


IMNN Financial Summary


Dec 23Dec 22Dec 21
Revenue-$500.00K$500.00K
Operating Income$-21.03M$-24.92M$-21.01M
Net Income$-19.51M$-35.90M$-20.77M
EBITDA$-20.31M$-19.53M$-19.39M
Basic EPS$-2.16$-5.03$-3.83
Diluted EPS$-2.16$-5.03$-3.83

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 07, 24 | 5:11 PM
Q2 24Aug 14, 24 | 2:55 PM
Q1 24May 13, 24 | 12:00 AM

Peer Comparison


TickerCompany
SNTISenti Biosciences, Inc.
BLCMBellicum Pharmaceuticals, Inc.
CYCCCyclacel Pharmaceuticals, Inc.
XCURExicure, Inc.
HSTOHistogen Inc.
LSTALisata Therapeutics, Inc.
SABSSAB Biotherapeutics, Inc.
LIXTLixte Biotechnology Holdings, Inc.
TOVXTheriva Biologics, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
DFFNCervoMed Inc.
HILSTharimmune, Inc.
CINGCingulate Inc.
KAKineta, Inc.
AVTXAvalo Therapeutics, Inc.
DMACDiaMedica Therapeutics Inc.
NLTXNeurogene Inc.
CBIOGyre Therapeutics, Inc.
LUMOLumos Pharma, Inc.